Methylation profiles in breast cancer

Cancer Investigation

Volumn 27, Issue 3, 2009, Pages 307-312

  Buyru, Nur ^a   Altinisik, Julide ^a   Ozdemir, Filiz ^a   Demokan, Semra ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; DNA methylation; MS MLPA

Indexed keywords

APC; BRCA1 PROTEIN; CADHERIN; CASPASE 8; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEATH ASSOCIATED PROTEIN KINASE; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE P1; HERMES ANTIGEN; METHYLTESTOSTERONE; PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VON HIPPEL LINDAU PROTEIN; APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CDKN2B PROTEIN, HUMAN; DEATH-ASSOCIATED PROTEIN KINASE; GSTP1 PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER TISSUE; CONTROLLED STUDY; EPIGENETICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; DNA METHYLATION; FEMALE; GENETICS; NUCLEIC ACID AMPLIFICATION;

APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 63349105568     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802350814     Document Type: Article

References (40)

1. Perkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94, 153-156.
2. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16, 6-21. (Pubitemid 34049633)
3. Das, P.M.; Singal, R. DNA methylation and cancer J Clin Oncol 2004, 22, 4632-4642.
4. Herman, J.G.; Baylin, S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349, 2042-2054. (Pubitemid 37448928)
5. Esteller, M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21, 5427-5440. (Pubitemid 34983479)
6. Widschwendter, M.; Jones, P.A. DNA methylation and breast carcinogenesis. Oncogene 2002, 21, 5462-5482.
7. Laird, P.W.; Jackson-Grusby, L.; Fazeli, A.; Dickinson, S.L.; Jung, W.E.; Li, E.;Weinberg, R.A.; Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995, 81, 197-205.
8. Ramchandani, S.; MacLeod, A.R.; Pinard, M.; von Hofe, E.; Szyf, M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1997, 94, 684-689. (Pubitemid 27053694)
9. Fackler, M.J.; McVeigh, M.; Mehrotra, J.; Marissa, A.B.; Lange, J.; Lapides, A.; Garrett, E.; Argani, P.; Sukumur, S. Quantitative multiplex methylation-specific PCR assay for detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004, 64, 4442-4452. (Pubitemid 38856915)
10. Nygren, A.O.H.; Ameziane, N.; Duarte, H.M.B.; Vijzelaar, R.N.C.P.; Waisfisz, Q.; Hess, C.J.; Schouten, J.P.; Errami A. Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005, 33, e128.
11. Burbee, D.G.; Forgacs, E.; Zochbauer-Muller, S.; Shivakumar, L.; Fong, K.; Gao, B.; Randle, D.; Kondo, M.; Virmani, A.; Bader, S.; Sekido, Y.; Latif, F.; Milchgrub, S.; Toyooka, S.; Gazdar, A.F.; Lerman, M.I.; Zabarovsky, E.; White, M.; Minna, J.D. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001, 93, 691-699.
12. Muller, H.M.; Widdschwendter, A.; Fiegl, H.; Ivarsson, L.; Goebel, G.; Perkmann, E.; Marth, C.; Widschwendter, M. DNA methylation in serum of breast cancer patients. An independent prognostic marker. Cancer Res 2003, 63, 7641-7645.
13. Dulaimi, E.; Hillinck, J.; Ibanez de Caceres, I.; Al-Saleem, T.; Cairns, P. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004, 10, 6189-6193. (Pubitemid 39287525)
14. Stearns, V.; Zhau, Q.; Davidson, N.E. Epigenetic regulation as a new target for breast cancer therapy. Cancer Invest 2007, 25, 659-665. (Pubitemid 350223167)
15. Dammann, R.; Schagdarsurengin, U.; Seidel, C.; Strunnikova, M.; Rastetter, M.; Baier, K.; Pfeifer, G.P. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 2005, 20, 645-663. (Pubitemid 40468282)
16. Dammann, R.; Yang, G.; Pfeifer G.P. Hypermethylation of the CpG island of Ras association domain family A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001, 61, 3105-3109.
17. Fackler, M.J.; McVeigh, M.; Evron, E.; Garret, E.; Mehrotra, J.; Polyak, K.; Sukumur, S.; Argani, P. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2, and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003, 107, 970-975.
18. Shukla, S.; Mirza, S.; Sharma, G.; Parshad, R.; Gupta, S.D.; Ralhan, R. Detection of RASSF1A and RARβ hypermethylation in serum DNA from breast cancer patients. Epigenetics 2006, 1, 88-93.
19. Krassenstein, R.; Sauter, E.; Dulaimi, E.; Battagli, C.; Ehya, H.; Klein-Szanto, A.; Cairns, P. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004, 10, 28-32. (Pubitemid 38114158)
20. Daniel, V. Glutathione S-transferases: gene structure and regulation of expression. Crit Rev Biochem Mol Biol 1993, 28, 173-207.
21. Arai, T.; Miyoshi, Y.; Kim, S.J.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 2006, 100, 659-665. (Pubitemid 44631918)
22. Esteller, M.; Corn, P.G.; Urena, J.M.; Gabrielson, E.; Baylin, S.B.; Herman, J.G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998, 58, 4515-4518. (Pubitemid 28480605)
23. Mehrotra, J.; Gaupat, M.M.; Kanaan, Y.; Fackler, M.J.; McVeigh, M.; Lahti-Domanici, J.; Polyak, K.; Argani, P.; Naab, T.; Garrett, E.; Parmigiani, G.; Broome, C.; Sukumar, S. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 2004, 10, 2052-2057. (Pubitemid 38375566)
24. Kim, W.Y.; Sharpless, N.E. The regulation of INK4/ARF in cancer and aging. Cell 2006, 127, 265-275.
25. Drexler, H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18, and p19 in human leukaemia-lymphoma cells. Leukemia 1998, 12, 845-859.
26. Zhang, Y.; Lou, F.; Yu, L. Study on the methylation of p15 gene CpG islands in acute leukemia: using methylation-specific PCR method. Zhonghua Xue Ye Xue Za Zhi 1999, 20, 628-630.
27. Dodge, J.E.; Munson, C.; List, A.F. KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients. Leukemia Res 2001, 25, 917-925.
28. Dodge, J.E; List, A.F.; Futscher, B.W. Selective variegated methylation of the p15 CpG island in acutemyeloid leukemia. Int J Cancer 1998, 78, 561-567.
29. Aggerholm, A.; Guldberg, P.; Hokland, M.; Hokland, P. Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res 1999, 59, 436-441. (Pubitemid 29048880)
30. Herman, J.G.; Jen, J.; Merlo, A.; Baylin, S.B. Hypermethylation- associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 1996, 56, 722-727. (Pubitemid 26060512)
31. Wang, Y.; Zhang, D., Zheng, W.; Luo, J.; Bai, Y.; Lu, Z. Multiple gene methylation of non-small-cell lung cancers evaluated with 3- dimensional microarray. Cancer 2008, 112, 1325-1336.
32. Lindberg, D.; Akerström, G.; Westin, G. Evaluation of CDKN2C/p18, CDKN1B/p27, and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN-1 associated pancreatic endocrine tumors. Clin Endocrinol 2008, 68, 271-277.
33. Tlsty, T.D.; Crawford, Y.G.; Holst, C.R.; Fordyce, C.A.; Zhang, J.; McDermott, K.; Kozakiewicz, K.; Gauthier, M.L. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J. Mammary Gland Biol Neoplasia 2004, 9, 263-274.
34. Serrano, M.; Hannon, G.J.; Beach,D. A newregulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366, 704-707. (Pubitemid 24036021)
35. Calmon, M.F.; Colombo, J.; Carvalho, F.; Souzo, F.P.; Filho, J.F.G.; Fukuyama, E.E.; Camarga, A.A.; Caballero, O.L.S.; Tajara, E.H.; Cordello, J.A.; Rahal, P. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM 23 in head and neck cancer. Cancer Genet Cytogenet 2007, 173, 31-37.
36. Kang, S.; Kim, J.W.; Kang, G.H.; Park, N.H.; Song, Y.S.; Kang, S.B.; Lee, H.P. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005, 97, 173-180.
37. Kissil, J.L.; Feinstein, E.; Cohen, O.; Jones, P.A.; Tsai, Y.C.; Knowles, M.A.; Eydman, M.E.; Kimichi, A. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 1997, 15, 403-407.
38. Tang, X.; Khuri, F.R.; Lee, J.J.; Kemp, B.L.; Liu, D.; Hong, W.X.; Mao, L. Hypermethylation of the death associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-lung cancer. J Natl Cancer Inst 2000, 92, 1511-1516. (Pubitemid 30757424)
39. Henken, F.E.; Wilting, S.M.; Overmeer, R.M.; van Rietschoten, J.G.I.; Nygren, A.O.H.; Schouten, J.P.; Meijer, C.J.L.M.; Snijders, P.J.F.; Steenbergen R.D.M. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 2007, 97, 1457-1464.
40. Feinberg, A.P.; Ohlsson, R.; Henikoff, S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006, 7, 21-33. (Pubitemid 41828945)